Radisens licenses Tecan’s microfluidic patent portfolio

 In Industry News, Radisens News

Cork, Ireland – February 23, 2012 − Radisens Diagnostics has announced a licensing deal with Tecan Trading AG., securing rights to Tecan’s industry leading centrifugal microfluidic patent portfolio.

The licensed technology consists of a wide range of fundamental centrifugal microfluidic processes and structures which enable automated fluid processing of small sample volumes including valving, metering and mixing.  Also covered are specific applications including affinity-binding based assays and enzymatic assays.

Jerry O’Brien, CEO Radisens Diagnostics said, “Tecan’s significant IP portfolio of granted patents cover novel and pioneering centrifugal microfluidic technologies, enabling Radisens to integrate multiple chronic and acute blood tests at the advanced performance and cost targets required at point-of-care”.

In related news, Dr. Greg Kellogg has joined Radisens Diagnostics as Product Development Director and Boston Office Manager. Greg is an internationally recognised pioneer of centrifugal microfluidics with a proven track record of innovative technology development and has built innovative R&D organizations while at Gamera, Tecan, Network Biosystems and Protiveris. Throughout his career, he has developed novel microfluidic technologies with applications in clinical and molecular diagnostics, genotyping, drug discovery and forensics, developing disposables, instrumentation and reagent products.

About Radisens Diagnostics

Radisens’ mission – to help shape decisions in healthcare by developing a point of care monitoring platform for integrated care management; testing at the right place, at the right time to enable better informed clinical interventions.

Radisens’ focus is to improve the management of high cost chronic diseases. Our early focus is on diabetes and cardiovascular disease, and their associated complexities and complications.

Our vision is to empower both those living with these conditions and their healthcare providers to reduce the challenges and costs of managing these conditions.

Radisens Diagnostics Limited is an established in vitro diagnostics company and was incorporated in 2009 based in Cork, Ireland.

 

Commercial contact:
Jerry O’Brien
Radisens Diagnostics Ltd
E: info @ radisens.com
T: +353 21 4868190 / Fax: +353 21 4928909

Recent Posts

Leave a Comment